Label: HYALURONIC ACID MICRO- hyaluronate sodium patch

  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated August 6, 2015

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active Ingredient: Sodium hyaluronate 95.0%

  • INACTIVE INGREDIENT

    Inactive Ingredient: Lactose

  • PURPOSE

    Purpose: Skin Protectant

  • WARNINGS

    Warnings: 1. Do not use if irritation occurs. 2. Avoid using on sensitive skin. 3. Keep out of reach of children 4. For external use only. 5. Store in a cool place

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of babies and children

  • INDICATIONS & USAGE

    Indications & usage:1. Take a patch out of the pouch with dry hand after face washing. 2. Try not to touch the middle side (needle) and take off the protective film carefully. 3. Place and attach the middle side of the patch on a desired area vertically. 4. Press the middle part of the patch attached with fingers several times. 5. Go to bed with patch attached and take it off the next morning.

  • DOSAGE & ADMINISTRATION

    Dosage & Administration: 2-3 times a week.

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    Image of carton

  • INGREDIENTS AND APPEARANCE
    HYALURONIC ACID MICRO 
    hyaluronate sodium patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70018-010
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM1.14 g  in 4 
    Inactive Ingredients
    Ingredient NameStrength
    Lactose (UNII: J2B2A4N98G)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70018-010-014 in 1 CARTON; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other07/01/2015
    Labeler - JUNMOK INTERNATIONAL,INC (689045829)
    Registrant - JUNMOK INTERNATIONAL,INC (689045829)
    Establishment
    NameAddressID/FEIBusiness Operations
    JUNMOK INTERNATIONAL,INC689045829manufacture(70018-010)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!